Public Profile

Sanofi S.p.A.

Sanofi S.p.A., a prominent player in the global pharmaceutical industry, is headquartered in Italy and operates extensively across Europe, North America, and Asia. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has since achieved significant milestones, including advancements in biotechnology and vaccine development. Specialising in prescription medicines, vaccines, and consumer healthcare products, Sanofi is renowned for its innovative therapies in areas such as diabetes, oncology, and rare diseases. Its commitment to research and development sets it apart, enabling the launch of unique products that address unmet medical needs. With a strong market position, Sanofi continues to be recognised for its contributions to public health and its dedication to improving patient outcomes worldwide.

DitchCarbon Score

How does Sanofi S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sanofi S.p.A.'s score of 55 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Sanofi S.p.A.'s reported carbon emissions

Sanofi S.p.A., headquartered in Italy, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their recent initiatives. This absence of data suggests that while Sanofi may be engaged in sustainability efforts, specific commitments or measurable achievements in carbon reduction are not disclosed at this time. As the pharmaceutical industry increasingly focuses on climate action, it will be important for Sanofi to establish and communicate clear targets to align with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sanofi S.p.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sanofi S.p.A. is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sanofi S.p.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bayer HealthCare LLC

US
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Chattem, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers